Gefitinib-Integrated Regimen versus Chemotherapy Alone in Heavily Pretreated Patients with Epidermal Growth Factor Receptor–Mutated Lung Adenocarcinoma: A Case-Control Study()()

BACKGROUND: The study aimed to compare the tolerability and efficacy of gefitinib combined with chemotherapy agents versus chemotherapy alone for the treatment of epidermal growth factor receptor (EGFR)–mutated lung adenocarcinoma in heavily pretreated patients. METHODS: The study was designed as a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Nan-Jie, Sun, Zhao, Wang, Yuzhou, Ning, Xiaohong, Jia, Ning, Meng, Changting, Wang, Yingyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202800/
https://www.ncbi.nlm.nih.gov/pubmed/24954357
http://dx.doi.org/10.1016/j.tranon.2014.05.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202800/
https://www.ncbi.nlm.nih.gov/pubmed/24954357
http://dx.doi.org/10.1016/j.tranon.2014.05.005

Ejemplares similares